Announce Date | 02/25/2025 |
EPS Normalized Actual | $0.72 (Beat by $0.02) |
EPS GAAP Actual | $0.72 (Beat by $0.02) |
Revenue Actual | $2.502B |
Revenue Surprise | Beat by $2502M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.86505 |
EPS GAAP Estimate | $0.86505 |
Revenue Estimate | $2.672125665B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.82465 | 19.85 | 4.70665 | 5.06728 | 4 |
Dec 2028 | 4.70031 | 20.38 | 4.64925 | 4.77061 | 7 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.57 | -0.24969 | 2.502B | 0.94% | -79.84M |
FQ3 2024 (Sep 2024) | 0.53 | -1.00737 | 2.454B | 5.09% | -2995.5M |
FQ2 2024 (Jun 2024) | 0.45 | -0.88835 | 2.51113B | 3.55% | -2332.87M |
FQ1 2024 (Mar 2024) | 0.5 | -0.04 | 2.459B | 4.35% | 118.51M |
FQ4 2023 (Dec 2023) | 0.91 | 0.91 | 2.4785B | 100% | 2478.5M |
FQ4 2017 (Dec 2017) | 0 | 0 | 1.761B | 100% | 1761M |
FQ1 2018 (Mar 2018) | 0.0543 | 0.0543 | 1.8B | 100% | 1800M |
FQ3 2023 (Sep 2023) | 0.41 | 0.41 | 2.329B | 100% | 2329M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.86505
Consensus Revenue Estimates
2.672125665B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.05104 | -- | 1.05104 | 1.05104 | 3 |
FQ2 2027 (Jun 2027) | 1.03607 | -- | 1.03607 | 1.03607 | 5 |
FQ1 2027 (Mar 2027) | 1.02288 | -- | 1.02288 | 1.02288 | 3 |
FQ4 2026 (Dec 2026) | 1.0081 | -- | 0.99664 | 1.01797 | 8 |
FQ3 2026 (Sep 2026) | 0.96817 | -- | 0.95717 | 0.97765 | 8 |
FQ2 2026 (Jun 2026) | 0.97815 | -- | 0.96703 | 0.98773 | 8 |
FQ1 2026 (Mar 2026) | 0.97815 | -- | 0.96703 | 0.98773 | 8 |
FQ4 2025 (Dec 2025) | 0.87279 | 34.69 | 0.86287 | 0.88134 | 9 |
FQ3 2025 (Sep 2025) | 0.8173 | 35.15 | 0.80514 | 0.83205 | 4 |
FQ2 2025 (Jun 2025) | 0.86505 | 47.98 | 0.85218 | 0.88066 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.88B | -- | 2.88B | 2.88B | 3 |
FQ2 2027 (Jun 2027) | 2.93B | -- | 2.93B | 2.93B | 3 |
FQ1 2027 (Mar 2027) | 2.8B | -- | 2.8B | 2.8B | 3 |
FQ4 2026 (Dec 2026) | 2.87B | -- | 2.85B | 2.89B | 5 |
FQ3 2026 (Sep 2026) | 2.82B | -- | 2.79B | 2.84B | 4 |
FQ2 2026 (Jun 2026) | 2.82B | -- | 2.8B | 2.84B | 5 |
FQ1 2026 (Mar 2026) | 2.76B | -- | 2.74B | 2.78B | 4 |
FQ4 2025 (Dec 2025) | 2.68B | 6.55 | 2.65B | 2.7B | 4 |
FQ3 2025 (Sep 2025) | 2.59B | 5.21 | 2.56B | 2.62B | 2 |
FQ2 2025 (Jun 2025) | 2.67B | 6.03 | 2.64B | 2.71B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.81969 | 0.57 | -0.24969 | -43.81% |
FQ3 2024 (Sep 2024) | 1.53737 | 0.53 | -1.00737 | -190.07% |
FQ2 2024 (Jun 2024) | 1.33835 | 0.45 | -0.88835 | -197.41% |
FQ1 2024 (Mar 2024) | 0.54 | 0.5 | -0.04 | -8% |
FQ4 2023 (Dec 2023) | 0.91 | 0.91 | 100% | |
FQ4 2017 (Dec 2017) | 0 | 0 | NAN% | |
FQ1 2018 (Mar 2018) | 0.0543 | 0.0543 | 100% | |
FQ3 2023 (Sep 2023) | 0.41 | 0.41 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $2.58B | $2.5B | $-79.84M | -3.19% |
FQ3 2024 (Sep 2024) | $5.45B | $2.45B | $-2995.5M | -122.07% |
FQ2 2024 (Jun 2024) | $4.84B | $2.51B | $-2332.87M | -92.9% |
FQ1 2024 (Mar 2024) | $2.34B | $2.46B | $118.51M | 4.82% |
FQ4 2023 (Dec 2023) | $0B | $2.48B | $2478.5M | 100% |
FQ4 2017 (Dec 2017) | $0B | $1.76B | $1761M | 100% |
FQ1 2018 (Mar 2018) | $0B | $1.8B | $1800M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.33B | $2329M | 100% |